This move is archived. Current quotes and coverage live on the stock page.
Get ADK alerts:
Diagnos Inc is seeing a notable rise in its stock price, reflecting positive market sentiment.
Diagnos Inc (ADK.V) is up today, gaining 3.64% in value as it trades at CA$0.28. This increase comes amid a generally cautious market, highlighting investor interest in the company’s potential.
Advertisement
Diagnos Inc
ADK.V
ADK.V
Diagnos Inc
WealthAwesomeMarket cap
$58.10M
52W high
$0.52
52W low
$0.18
1W change
-2.04%
Beta
0.05
Analyst Price Targets
Based on analyst covering ADK
Wall Street analysts forecast ADK stock price to rise 212.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.50
+212.5% Upside
Current Price
C$0.48
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ADK's historical volatility
30-Day Vol
88.4%
Annualized
90-Day Vol
74.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.57
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.51 | C$0.38 – C$0.69 |
| 60 trading days | C$0.54 | C$0.35 – C$0.83 |
| 90 trading days | C$0.57 | C$0.34 – C$0.97 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While the stock's rise is encouraging, investors should stay cautious due to the company's small market cap and limited coverage.
3.64% Increase in Stock Price
Diagnos Inc's stock has risen by 3.64% today, indicating growing interest from investors despite its small market size.
Bull case
The recent changes to convertible debentures may indicate that Diagnos Inc is becoming more financially flexible, which could improve its growth prospects.
Bear case
With a market cap of just CA$33 million, Diagnos Inc remains a speculative investment, and its stock price can be quite volatile.
Stock Performance Overview
Advertisement
Diagnos Inc's stock has shown a positive trend today, climbing 3.64% to a trading price of CA$0.28. This increase is particularly noteworthy given the company's small market cap of CA$33 million, which can often lead to heightened volatility in stock prices.
Recent Company Developments
While there have been no recent announcements directly impacting the stock today, the company's previous changes to convertible debentures could be contributing to the current investor optimism. These financial moves may suggest a strategic approach to managing capital and future growth.
Market Sentiment and Future Outlook
Despite the positive movement in Diagnos Inc's stock, investors should approach with caution. The limited coverage and small-cap nature of the company mean that any fluctuations can be pronounced. It's essential to keep an eye on broader market trends and company developments that could affect future performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
